Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing

Rensing-Ehl, A., M. R. Lorenz, M. Fuhrer, W. Willenbacher, E. Willenbacher, S. Sopper, M. Abinun, M. E. Maccari, C. Konig, P. Haegele, S. Fuchs, C. Castro, P. Kury, O. Pelle, C. Klemann, M. Heeg, J. Thalhammer, O. Wegehaupt, M. Fischer, S. Goldacker, B. Schulte, S. Biskup, P. Chatelain, V. Schuster, K. Warnatz, B. Grimbacher, A. Meinhardt, D. Holzinger, P. T. Oommen, T. Hinze, H. Hebart, K. Seeger, K. Lehmberg, T. R. Leahy, A. Claviez, S. Vieth, F. H. Schilling, I. Fuchs, M. Gross, F. Rieux-Laucat, A. Magerus, C. Speckmann, K. Schwarz, S. Ehl, and A. s. group. 2023. Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing. J Allergy Clin Immunol. doi:10.1016/j.jaci.2023.11.006.

Categorised in:

This post was written by Heike Ufheil